Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.

Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.

PMID:
26757747
2.

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis.

Shi J, van Steenbergen HW, van Nies JA, Levarht EW, Huizinga TW, van der Helm-van Mil AH, Toes RE, Trouw LA.

Arthritis Res Ther. 2015 Nov 24;17:339. doi: 10.1186/s13075-015-0860-6.

3.

IL2RA is associated with persistence of rheumatoid arthritis.

van Steenbergen HW, van Nies JA, Ruyssen-Witrand A, Huizinga TW, Cantagrel A, Berenbaum F, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Sep 8;17:244. doi: 10.1186/s13075-015-0739-6.

4.

Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.

Ajeganova S, van Steenbergen HW, van Nies JA, Burgers LE, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 May;75(5):867-73. doi: 10.1136/annrheumdis-2014-207080. Epub 2015 May 13.

PMID:
25972519
5.

Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH.

van Nies JA, Alves C, Radix-Bloemen AL, Gaujoux-Viala C, Huizinga TW, Hazes JM, Brouwer E, Fautrel B, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Apr 23;17:108. doi: 10.1186/s13075-015-0616-3.

6.

Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts.

van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 May;74(5):806-12. doi: 10.1136/annrheumdis-2014-206047. Epub 2015 Jan 5.

PMID:
25561360
7.

Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.

Humphreys JH, van Nies JA, Chipping J, Marshall T, van der Helm-van Mil AH, Symmons DP, Verstappen SM.

Arthritis Res Ther. 2014 Dec 4;16(6):483. doi: 10.1186/s13075-014-0483-3.

8.

Is the modified disease activity score superior to the disease activity score in early arthritis and rheumatoid arthritis? Comment on the article by Baker et al.

Nieuwenhuis WP, van Nies JA, Reijnierse M, van der Heijde D, van der Helm-Van Mil AH.

Arthritis Rheumatol. 2014 Nov;66(11):3244-5. doi: 10.1002/art.38807. No abstract available.

9.

MRI-detected subclinical joint inflammation is associated with radiographic progression.

Krabben A, Stomp W, van Nies JA, Huizinga TW, van der Heijde D, Bloem JL, Reijnierse M, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Nov;73(11):2034-7. doi: 10.1136/annrheumdis-2014-205208. Epub 2014 Jul 29.

PMID:
25074691
10.

Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.

van Steenbergen HW, van Nies JA, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Arthritis Res Ther. 2014 Apr 10;16(2):R92. doi: 10.1186/ar4536.

11.

Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI.

van Steenbergen HW, van Nies JA, Huizinga TW, Bloem JL, Reijnierse M, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 Jun;74(6):1225-32. doi: 10.1136/annrheumdis-2014-205522. Epub 2014 Apr 9.

PMID:
24718962
12.

Does a genetic variant in FOXO3A predict a milder course of rheumatoid arthritis?

van Steenbergen HW, Rantapää-Dahlqvist S, van Nies JA, Berglin E, Huizinga TW, Gregersen PK, van der Helm-van Mil AH.

Arthritis Rheumatol. 2014 Jun;66(6):1678-81. doi: 10.1002/art.38405. No abstract available.

13.

Evaluating processes underlying the predictive value of baseline erosions for future radiological damage in early rheumatoid arthritis.

van Nies JA, van Steenbergen HW, Krabben A, Stomp W, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 May;74(5):883-9. doi: 10.1136/annrheumdis-2013-204659. Epub 2014 Jan 15.

PMID:
24431393
14.

Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts.

de Rooy DP, van Nies JA, Kapetanovic MC, Kristjansdottir H, Andersson ML, Forslind K, van der Heijde DM, Gregersen PK, Lindqvist E, Huizinga TW, Gröndal G, Svensson B, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Jul;73(7):1384-7. doi: 10.1136/annrheumdis-2013-203940. Epub 2014 Jan 3.

PMID:
24389296
15.

Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts.

Krabben A, Wilson AG, de Rooy DP, Zhernakova A, Brouwer E, Lindqvist E, Saxne T, Stoeken G, van Nies JA, Knevel R, Huizinga TW, Toes R, Gregersen PK, van der Helm-van Mil AH.

Arthritis Rheum. 2013 Dec;65(12):3051-7. doi: 10.1002/art.38141.

16.

Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis.

Knevel R, Klein K, Somers K, Ospelt C, Houwing-Duistermaat JJ, van Nies JA, de Rooy DP, de Bock L, Kurreeman FA, Schonkeren J, Stoeken-Rijsbergen G, Helmer Q, van der Linden MP, Kern M, Manjarrez-Orduno N, Rodriguez-Rodriquez L, Stinissen P, Huizinga TW, Toes RE, Gay S, Gregersen PK, Somers V, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Nov;73(11):2038-46. doi: 10.1136/annrheumdis-2013-204050. Epub 2013 Aug 16.

PMID:
23956247
17.

Is early remission associated with improved survival or is arthritis persistency associated with increased mortality in early arthritis? Comparisons with the general population.

van Nies JA, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Nov;72(11):e25. doi: 10.1136/annrheumdis-2013-204182. Epub 2013 Jul 12. No abstract available.

PMID:
23852696
18.

Long-term outcome of rheumatoid arthritis defined according to the 2010-classification criteria.

Burgers LE, van Nies JA, Ho LY, de Rooy DP, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Feb;73(2):428-32. doi: 10.1136/annrheumdis-2013-203402. Epub 2013 May 9.

PMID:
23661495
19.

Anaemia to predict radiographic progression in rheumatoid arthritis.

van Steenbergen HW, van Nies JA, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Jul;72(7):e16. doi: 10.1136/annrheumdis-2013-203718. Epub 2013 Apr 26. No abstract available.

PMID:
23625976
20.

What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review.

van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 May;73(5):861-70. doi: 10.1136/annrheumdis-2012-203130. Epub 2013 Apr 9. Review.

PMID:
23572339
21.

MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis.

Krabben A, Stomp W, van der Heijde DM, van Nies JA, Bloem JL, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Sep 1;72(9):1540-4. doi: 10.1136/annrheumdis-2012-202628. Epub 2013 Jan 19.

PMID:
23334211
22.

Reasons for medical help-seeking behaviour of patients with recent-onset arthralgia.

van Nies JA, Brouwer E, de Rooy DP, van Gaalen FA, Huizinga TW, Posthumus MD, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Aug;72(8):1302-7. doi: 10.1136/annrheumdis-2012-201995. Epub 2012 Sep 6.

PMID:
22956597
23.

Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics.

van Nies JA, Brouwer E, van Gaalen FA, Allaart CF, Huizinga TW, Posthumus MD, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Aug;72(8):1295-301. doi: 10.1136/annrheumdis-2012-202289. Epub 2012 Sep 5.

PMID:
22952388
24.

Evaluation of the contribution of cumulative levels of inflammation to the variance in joint destruction in rheumatoid arthritis.

Knevel R, van Nies JA, le Cessie S, Huizinga TW, Brouwer E, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Feb;72(2):307-8. doi: 10.1136/annrheumdis-2012-201931. Epub 2012 Aug 17. No abstract available.

PMID:
22904258
25.

Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohorts.

Knevel R, de Rooy DP, Gregersen PK, Lindqvist E, Wilson AG, Gröndal G, Zhernakova A, van Nies JA, Toes RE, Tsonaka R, Houwing-Duistermaat JJ, Steinsson K, Huizinga TW, Saxne T, van der Helm-van Mil AH.

Ann Rheum Dis. 2012 Oct;71(10):1753-5. doi: 10.1136/annrheumdis-2012-201289. Epub 2012 May 14. No abstract available. Erratum in: Ann Rheum Dis. 2012 Dec;71(12):2064.

PMID:
22586175
26.

No impact of serum uric acid on the outcome of recent-onset arthritis.

Luczak A, Knevel R, Huizinga TW, van Nies JA, van der Helm-van Mil A, De Vries-Bouwstra JK.

Ann Rheum Dis. 2012 Aug;71(8):1424-5. doi: 10.1136/annrheumdis-2011-201027. Epub 2012 Mar 22. No abstract available.

PMID:
22440824
27.

Interactive seminars or small group tutorials in preclinical medical education: results of a randomized controlled trial.

de Jong Z, van Nies JA, Peters SW, Vink S, Dekker FW, Scherpbier A.

BMC Med Educ. 2010 Nov 13;10:79. doi: 10.1186/1472-6920-10-79.

28.

Improved treatment strategies reduce the increased mortality risk in early RA patients.

van Nies JA, de Jong Z, van der Helm-van Mil AH, Knevel R, Le Cessie S, Huizinga TW.

Rheumatology (Oxford). 2010 Nov;49(11):2210-6. doi: 10.1093/rheumatology/keq250. Epub 2010 Aug 9.

PMID:
20696679
29.

The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis.

van Nies JA, Knevel R, Daha N, van der Linden MP, Gregersen PK, Kern M, le Cessie S, Houwing-Duistermaat JJ, Huizinga TW, Toes RE, van der Helm-van Mil AH.

Ann Rheum Dis. 2010 Sep;69(9):1730-1. doi: 10.1136/ard.2009.117952. Epub 2010 Apr 13. No abstract available.

30.

TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies.

van Nies JA, Marques RB, Trompet S, de Jong Z, Kurreeman FA, Toes RE, Jukema JW, Huizinga TW, van der Helm-van Mil AH.

Arthritis Res Ther. 2010;12(2):R38. doi: 10.1186/ar2947. Epub 2010 Mar 5.

Supplemental Content

Loading ...
Support Center